Maureen Cooper

Maureen Cooper has a degree in Bioinformatics from the City University of New York and has spent over 15 years in the molecular diagnostics space. Her experience includes academic research at the University of Pittsburgh as well as industry where she has held multiple Commercial and Medical Affairs roles. Over the course of her career, Maureen has focused on educating Oncologists and Pathologists on the value of biomarker testing for cancer patients and building testing pathways for Oncology programs through education and collaboration.

The clinical relevance of anti-DFS70 autoantibodies

 

Presentation on the use of the anti-DFS70 antibodies to help identify ANA-positive individuals who do not have an ANA-associated autoimmune disease (AARD), especially in the absence of significant clinical findings.

Speaker

Vincent Ricchiuti, PhD Laboratory Director and Discipline Director in Immunology, Labcorp

Pri-med Post Event Form